cervical cancer screening

Back in February, several prominent medical associations made a recommendation that the newly FDA approved HPV DNA test should replace pap smears or co-testing (pap smear and HPV assay) as the primary mechanism for detecting cervical cancer for all age groups.
A new study conducted by the National Institutes of health s National Cancer Institute has found that negative tests for the human papillomavirus virus (HPV) are more reliable in predicting